Testing a device to help blind people with daily tasks
Part of Brain & nervous system, Eyes & vision clinical trials.
This trial tests a new device (ARIA) that helps people who are blind navigate daily tasks. If you have no light perception or only light perception, use a long cane, and are comfortable with a smartphone, you may be able to take part in 4 sessions in Sydney.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older
- You have no light perception or only light perception (cannot see shapes or movement)
- You can stand or walk for at least 30 minutes at a time and use a long cane to travel independently
- You can have a conversation without hearing aids (no more than mild-to-moderate hearing loss)
- You have a smartphone and have used an app or device for wayfinding, and you can attend 4 sessions in Haymarket, Sydney
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if small sensors attached to magnifiers and remote rehab sessions can help people with low vision use their new devices more. You may join if you recently got a magnifier or vision app and can attend visits.
This study tests a virtual assistant that helps people with low vision navigate daily tasks. Researchers will see if it improves brain activity and real-world function.
This study tests a new AI system designed to improve what people with visual prostheses 'see.' If you have an implanted device like the Argus II or Orion, you may be able to help by coming to the lab for several days of vision testing.
This trial tests if a device that converts visual information into sound or touch can help people who are blind. Researchers will see how the brain adapts to using this new sense.
This early-stage study uses virtual reality tasks to check how well a person can move and function using their eyesight. It may help researchers measure vision abilities in a way that could guide future care for retinal disease.
This early safety study tests an implanted device placed in the brain to help people with very limited sight (no or minimal light). It focuses on whether the implant can be safely used and whether it may support vision-related signals over time.
Hear when a new Blindness and Low Vision trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.